Destiny Pharma plc – Result of Annual General Meeting and Strategy Update

Brighton, United Kingdom – 27 May 2022 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, announces that all resolutions proposed to shareholders at the Annual General Meeting held earlier today were duly passed.

Please read…